84 related articles for article (PubMed ID: 19941849)
1. Involvement of proteinase-activated receptors 1 and 2 in spreading and phagocytosis by murine adherent peritoneal cells: modulation by the C-terminal of S100A9 protein.
Pagano RL; Sampaio SC; Juliano MA; Juliano L; Giorgi R
Eur J Pharmacol; 2010 Feb; 628(1-3):240-6. PubMed ID: 19941849
[TBL] [Abstract][Full Text] [Related]
2. The C-terminus of murine S100A9 inhibits spreading and phagocytic activity of adherent peritoneal cells.
Pagano RL; Sampaio SC; Juliano L; Juliano MA; Giorgi R
Inflamm Res; 2005 May; 54(5):204-10. PubMed ID: 15953992
[TBL] [Abstract][Full Text] [Related]
3. Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides.
Hollenberg MD; Saifeddine M; al-Ani B; Kawabata A
Can J Physiol Pharmacol; 1997 Jul; 75(7):832-41. PubMed ID: 9315351
[TBL] [Abstract][Full Text] [Related]
4. Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2.
Mize GJ; Wang W; Takayama TK
Mol Cancer Res; 2008 Jun; 6(6):1043-51. PubMed ID: 18567807
[TBL] [Abstract][Full Text] [Related]
5. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J
Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244
[TBL] [Abstract][Full Text] [Related]
6. Activated protein C signals through the thrombin receptor PAR1 in endothelial cells.
Riewald M; Petrovan RJ; Donner A; Ruf W
J Endotoxin Res; 2003; 9(5):317-21. PubMed ID: 14577849
[TBL] [Abstract][Full Text] [Related]
7. Optical biosensor differentiates signaling of endogenous PAR1 and PAR2 in A431 cells.
Fang Y; Ferrie AM
BMC Cell Biol; 2007 Jun; 8():24. PubMed ID: 17587449
[TBL] [Abstract][Full Text] [Related]
8. The C-terminus of murine S100A9 protein inhibits hyperalgesia induced by the agonist peptide of protease-activated receptor 2 (PAR2).
Dale CS; Cenac N; Britto LR; Juliano MA; Juliano L; Vergnolle N; Giorgi R
Br J Pharmacol; 2006 Oct; 149(4):374-84. PubMed ID: 16967049
[TBL] [Abstract][Full Text] [Related]
9. Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis.
Shi X; Gangadharan B; Brass LF; Ruf W; Mueller BM
Mol Cancer Res; 2004 Jul; 2(7):395-402. PubMed ID: 15280447
[TBL] [Abstract][Full Text] [Related]
10. Effect of the C-terminus of murine S100A9 protein on experimental nociception.
Dale CS; Pagano Rde L; Paccola CC; Pinotti-Guirao T; Juliano MA; Juliano L; Giorgi R
Peptides; 2006 Nov; 27(11):2794-802. PubMed ID: 16920226
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of macrophage functions by the C-terminus of murine S100A9 is dependent on B-1 cells.
Pagano RL; Moraes NF; De Lorenzo BH; Coccuzzo Sampaio S; Mariano M; Giorgi R
Mediators Inflamm; 2014; 2014():836491. PubMed ID: 25276056
[TBL] [Abstract][Full Text] [Related]
12. Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs).
Oikonomopoulou K; Hansen KK; Saifeddine M; Vergnolle N; Tea I; Blaber M; Blaber SI; Scarisbrick I; Diamandis EP; Hollenberg MD
Biol Chem; 2006 Jun; 387(6):817-24. PubMed ID: 16800746
[TBL] [Abstract][Full Text] [Related]
13. Protease-activated receptor-1 can mediate responses to SFLLRN in thrombin-desensitized cells: evidence for a novel mechanism for preventing or terminating signaling by PAR1's tethered ligand.
Hammes SR; Coughlin SR
Biochemistry; 1999 Feb; 38(8):2486-93. PubMed ID: 10029543
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of proteinase-activated receptor-1 (PAR1) agonists and antagonists using a cultured cell receptor desensitization assay: activation of PAR2 by PAR1-targeted ligands.
Kawabata A; Saifeddine M; Al-Ani B; Leblond L; Hollenberg MD
J Pharmacol Exp Ther; 1999 Jan; 288(1):358-70. PubMed ID: 9862790
[TBL] [Abstract][Full Text] [Related]
15. A role for proteinase-activated receptor-1 in inflammatory bowel diseases.
Vergnolle N; Cellars L; Mencarelli A; Rizzo G; Swaminathan S; Beck P; Steinhoff M; Andrade-Gordon P; Bunnett NW; Hollenberg MD; Wallace JL; Cirino G; Fiorucci S
J Clin Invest; 2004 Nov; 114(10):1444-56. PubMed ID: 15545995
[TBL] [Abstract][Full Text] [Related]
16. Protease-activated receptor-1 (PAR1) and PAR2 but not PAR4 mediate relaxations in lower esophageal sphincter.
Huang SC
Regul Pept; 2007 Jul; 142(1-2):37-43. PubMed ID: 17335921
[TBL] [Abstract][Full Text] [Related]
17. Macrophage suppression following phagocytosis of apoptotic neutrophils is mediated by the S100A9 calcium-binding protein.
De Lorenzo BH; Godoy LC; Novaes e Brito RR; Pagano RL; Amorim-Dias MA; Grosso DM; Lopes JD; Mariano M
Immunobiology; 2010 May; 215(5):341-7. PubMed ID: 19656587
[TBL] [Abstract][Full Text] [Related]
18. Modulation of phagocytic function in murine peritoneal macrophages by bombesin, gastrin-releasing peptide and neuromedin C.
De la Fuente M; Del Rio M; Ferrandez MD; Hernanz A
Immunology; 1991 Jun; 73(2):205-11. PubMed ID: 1649124
[TBL] [Abstract][Full Text] [Related]
19. Signal transduction for formation/release of interleukin-8 caused by a PAR2-activating peptide in human lung epithelial cells.
Moriyuki K; Nagataki M; Sekiguchi F; Nishikawa H; Kawabata A
Regul Pept; 2008 Jan; 145(1-3):42-8. PubMed ID: 17854923
[TBL] [Abstract][Full Text] [Related]
20. Tethered ligand-derived peptides of proteinase-activated receptor 3 (PAR3) activate PAR1 and PAR2 in Jurkat T cells.
Hansen KK; Saifeddine M; Hollenberg MD
Immunology; 2004 Jun; 112(2):183-90. PubMed ID: 15147561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
